Absence of neuromuscular blocking activity of sparfloxacin.
Paradelis
A G
AG
Department of Pharmacology, Medical Faculty, Aristotle University of Thessaloniki, Macedonia, Greece.
Kouvelas
D
D
Pangalis
A
A
Argyriou
A
A
Salpigides
G
G
D000818:Animals; D000890:Anti-Infective Agents / Q000633:toxicity*; D003964:Diaphragm / Q000187:drug effects / Q000294:innervation; D004558:Electric Stimulation; D024841:Fluoroquinolones; D066298:In Vitro Techniques; D008297:Male; D009466:Neuromuscular Blocking Agents / Q000633:toxicity*; D010791:Phrenic Nerve / Q000187:drug effects; D015363:Quinolones / Q000633:toxicity*; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009466:Neuromuscular Blocking Agents; D015363:Quinolones; C061363:sparfloxacin